Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

QR Code

Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

None

Saved in:

Bibliographic Details
Main Author:	Wenya, Wang
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/22883
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
by: Kayed, Rakez
Published: (2011)

The Potential of Neurotrophic Factors for the Treatment of Parkinson’s Disease
by: Sullivan, Aideen M., et al.
Published: (2011)

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
by: Marco Agostini, et al.
Published: (2025-06-01)

Hypergravity and ERK Inhibition Combined Synergistically Reduce Pathological Tau Phosphorylation in a Neurodegenerative Cell Model
by: Valerio Mignucci, et al.
Published: (2025-07-01)

Therapeutic Potential of Polyphenols in Parkinson’s Disease
by: Mythri, Rajeswara Babu, et al.
Published: (2011)

Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies
by: Ampe, Ben, et al.
Published: (2011)

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease
by: Bogatkevich, Galina S., et al.
Published: (2012)

Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
by: Cunha-Oliveira, Teresa, et al.
Published: (2012)

Genetics of Parkinson Disease
by: Sassi, Celeste
Published: (2011)

Parkin and Parkinson’s Disease
by: Tay, Shiam-Peng, et al.
Published: (2011)

Update in Parkinson’s Disease
by: Carrillo, Fátima, et al.
Published: (2012)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
by: Toni T. Saari, et al.
Published: (2025-04-01)

The Execution Step in Parkinson’s Disease – On the Vicious Cycle of Mitochondrial Complex I Inhibition, Iron Dishomeostasis and Oxidative Stress
by: Núñez, Marco T., et al.
Published: (2012)

CFS Biomarkers in Parkinson’s Disease
by: Parnetti, Lucilla, et al.
Published: (2011)

Imaging Dyskinesias in Parkinson’s Disease
by: Politis, Marios, et al.
Published: (2011)

Cognitive Dysfunction in Parkinson’s Disease
by: Varanese, Sara, et al.
Published: (2011)

Gastrointestinal Dysfunction in Parkinson’s Disease
by: Krogh, Klaus
Published: (2011)

Etiology and Pathogenesis of Parkinson’s Disease
by: Hatano, Taku, et al.
Published: (2011)

Gene Therapy for Parkinson’s Disease
by: Douglas, Michael, et al.
Published: (2011)

Timing Control in Parkinson’s Disease
by: Almeida, Quincy J.
Published: (2012)

Parkinson’s Disease and the Immune System
by: Ward1, Roberta J., et al.
Published: (2012)

Role of FKBPs in Parkinson’s Disease
by: Chattopadhaya, Souvik, et al.
Published: (2012)

Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism
by: Huang, Chin-Chang, et al.
Published: (2012)

Wading into a Theoretical Model for Parkinson's Disease
by: Verzi, Diana W.
Published: (2012)

Diagnosis and Differential Diagnosis of Parkinson’s Disease
by: Lingor, Paul, et al.
Published: (2011)

How to Stay Active with Parkinson’s Disease
by: Qutubuddin, Abu
Published: (2011)

Cognition and Gait Disturbances in Parkinson's Disease
by: Ribarič, Samo
Published: (2011)

Nocturnal Disturbances in Patients with Parkinson’s Disease
by: Suzuki, Keisuke, et al.
Published: (2011)

Neuropsychological Deficits in Initial Parkinson’s Disease
by: Fernandez, Raquel Rodriguez, et al.
Published: (2011)

Cognitive and Psychiatric Aspects of Parkinson’s Disease
by: Stephani, Caspar
Published: (2011)

The Negative Impact of Apathy in Parkinson’s Disease
by: Leroi, Iracema
Published: (2011)

Analysis of Transcriptome Alterations in Parkinson’s Disease
by: Filatova, Elena, et al.
Published: (2011)

Inflammatory Responses and Regulation in Parkinson’s Disease
by: Peterson, Lynda J., et al.
Published: (2011)

Successes of Modelling Parkinson Disease in Drosophila
by: Staveley, Brian E.
Published: (2012)

Acetyl-L-Carnitine in Parkinson’s Disease
by: Sinicropi, Maria Stefania, et al.
Published: (2012)

Inflammation in Parkinson’s Disease: Causes and Consequences
by: Collins, Louise M., et al.
Published: (2012)

Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease
by: García-Sierra, Francisco, et al.
Published: (2011)

The Noradrenergic System is a Major Component in Parkinson’s Disease
by: Szot, Patricia, et al.
Published: (2011)

The Energy Crisis in Parkinson’s Disease: A Therapeutic Target
by: Abou-Hamdan, Mhamad, et al.
Published: (2011)

Botulinum A Toxin Intravesical Injections in the Treatment of Refractory Overactive Bladder in Patients with Parkinson's Disease
by: Giannantoni, Antonella, et al.
Published: (2011)